Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Single dose of acetylsalicylic acid in patients with Type 2 diabetes mellitus and/or chronic renal failure ameliorates anaemia by decreasing the rate of neocytolysis.

Wittmann I, Molnár GA, Wagner L, Köszegi T, Wagner Z, Laczy B, Tamaskó M, Markó L, Mohás M, Nagy J.

Acta Physiol Hung. 2007 Mar;94(1-2):159-66.

PMID:
17444284
2.

Neocytolysis contributes to the anemia of renal disease.

Rice L, Alfrey CP, Driscoll T, Whitley CE, Hachey DL, Suki W.

Am J Kidney Dis. 1999 Jan;33(1):59-62.

PMID:
9915268
3.

Diabetes mellitus increases the severity of anemia in non-dialyzed patients with renal failure.

Ishimura E, Nishizawa Y, Okuno S, Matsumoto N, Emoto M, Inaba M, Kawagishi T, Kim CW, Morii H.

J Nephrol. 1998 Mar-Apr;11(2):83-6.

PMID:
9589379
4.

Intravenous calcitriol improves anaemia and reduces the need for erythropoietin in haemodialysis patients.

Goicoechea M, Vazquez MI, Ruiz MA, Gomez-Campdera F, Perez-García R, Valderrábano F.

Nephron. 1998;78(1):23-7.

PMID:
9453399
5.

The effect of correction of anaemia in diabetics and non-diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron.

Silverberg DS, Wexler D, Blum M, Tchebiner JZ, Sheps D, Keren G, Schwartz D, Baruch R, Yachnin T, Shaked M, Schwartz I, Steinbruch S, Iaina A.

Nephrol Dial Transplant. 2003 Jan;18(1):141-6.

PMID:
12480972
6.

Beneficial influence of recombinant human erythropoietin therapy on the rate of progression of chronic renal failure in predialysis patients.

Jungers P, Choukroun G, Oualim Z, Robino C, Nguyen AT, Man NK.

Nephrol Dial Transplant. 2001 Feb;16(2):307-12.

PMID:
11158405
7.

The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period.

Silverberg DS, Blum M, Agbaria Z, Deutsch V, Irony M, Schwartz D, Baruch R, Yachnin T, Steinbruch S, Iaina A.

Clin Nephrol. 2001 Mar;55(3):212-9.

PMID:
11316241
8.

Erythropoietin depletion and anaemia in diabetes mellitus.

Winkler AS, Marsden J, Chaudhuri KR, Hambley H, Watkins PJ.

Diabet Med. 1999 Oct;16(10):813-9.

PMID:
10547207
9.

Erythropoietin response to anemia and its association with autonomic neuropathy in type 2 diabetic patients without advanced renal failure.

Kim MK, Baek KH, Lim DJ, Kim YK, Kang MI, Lee KW, Song KH.

J Diabetes Complications. 2010 Mar-Apr;24(2):90-5. doi: 10.1016/j.jdiacomp.2009.02.002. Epub 2009 Mar 19.

PMID:
19303331
10.

Erythropoietin response to hypoxia in patients with diabetic autonomic neuropathy and non-diabetic chronic renal failure.

Bosman DR, Osborne CA, Marsden JT, Macdougall IC, Gardner WN, Watkins PJ.

Diabet Med. 2002 Jan;19(1):65-9.

PMID:
11869305
11.

Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients.

Kuriyama S, Tomonari H, Yoshida H, Hashimoto T, Kawaguchi Y, Sakai O.

Nephron. 1997;77(2):176-85.

PMID:
9346384
12.

Current and potential applications for erythropoietin.

Pedrazzini A.

Acta Haematol. 1992;87 Suppl 1:2-3.

PMID:
1574962
13.

[Does long-term erythropoietin therapy influence the prevalence of serum markers of hepatitis B and C in haemodialysed uraemic patients?].

Mesjasz J, Wiecek A, Gonciarz Z, Mazur W, Kokot F.

Pol Merkur Lekarski. 2004 Apr;16(94):362-7. Polish.

PMID:
15517934
14.

Serum erythropoietin concentrations and responses to anaemia in patients with or without chronic kidney disease.

Artunc F, Risler T.

Nephrol Dial Transplant. 2007 Oct;22(10):2900-8. Epub 2007 Jun 7.

PMID:
17556407
15.

Prevalence and associations of low plasma erythropoietin in patients with Type 2 diabetes mellitus.

Mojiminiyi OA, Abdella NA, Zaki MY, El Gebely SA, Mohamedi HM, Aldhahi WA.

Diabet Med. 2006 Aug;23(8):839-44.

PMID:
16911620
16.
17.

Erythropoietin resistance and survival in non-dialysis patients with stage 4-5 chronic kidney disease and heart disease.

Guerrero-Riscos MÁ, Montes-Delgado R, Seda-Guzmán M, Praena-Fernández JM.

Nefrologia. 2012 May 14;32(3):343-52. doi: 10.3265/Nefrologia.pre2012.Jan.11111. Epub 2012 Apr 17. English, Spanish.

18.

Relationship between insulin resistance and erythropoietin responsiveness in hemodialysis patients.

Abe M, Okada K, Soma M, Matsumoto K.

Clin Nephrol. 2011 Jan;75(1):49-58.

PMID:
21176750
19.

Effect of erythropoietin on urinary liver-type fatty-acid-binding protein in patients with chronic renal failure and anemia.

Nakamura T, Sugaya T, Kawagoe Y, Suzuki T, Ueda Y, Koide H.

Am J Nephrol. 2006;26(3):276-80. Epub 2006 Jun 13.

PMID:
16772708
20.

Erythropoietin deficiency and relative resistance cause anaemia in post-renal transplant recipients with normal renal function.

Nampoory MR, Johny KV, al-Hilali N, Seshadri MS, Kanagasabhapathy AS.

Nephrol Dial Transplant. 1996 Jan;11(1):177-81.

PMID:
8649630

Supplemental Content

Support Center